Aaron T. Wecksler - Concepedia

Author

Aaron T. Wecksler

University of California, Santa Cruz ORCID

Also Known As

A. T. Wecksler, Aaron T Wecksler, Aaron T. Wecksler, Aaron Wecksler

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Santa Cruz University of California, Davis University of Illinois Urbana-Champaign Kaiser Permanente South San Francisco Medical Center Stanford University

About

Aaron T. Wecksler is an author at University of California, Santa Cruz specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1K
2	Biochemistry	12	12	796
3	Natural Sciences	11	11	767
4	Allergy	3	3	138
5	Engineering	1	1	26

Aaron T. Wecksler

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Monoclonal antibody targeting the β-barrel assembly machine of <i>Escherichia coli</i> is bactericidal Kelly M. Storek, Marcy R. Auerbach, Handuo Shi, Proceedings of the National Academy of Sciences	2018	176
Structural basis for dual-mode inhibition of the ABC transporter MsbA Hoangdung Ho, Anh Miu, Mary Kate Alexander, Nature Molecular PharmacologySignal TransductionMolecular PhysiologyBiochemistryNatural Sciences	2018	173
Synthesis and Structure−Activity Relationship Studies of Urea-Containing Pyrazoles as Dual Inhibitors of Cyclooxygenase-2 and Soluble Epoxide Hydrolase Sung Hee Hwang, Karen Wagner, Christophe Morisseau, Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryStructure−activity Relationship StudiesSoluble Epoxide HydrolaseMedicinal Chemistry	2011	170
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors Sung Hee Hwang, Aaron T. Wecksler, Guodong Zhang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2013	106
Targeted degradation via direct 26S proteasome recruitment Charlene Bashore, Sumit Prakash, Matthew C. Johnson, Nature Chemical Biology	2022	100
Effect of ambient light on IgG1 monoclonal antibodies during drug product processing and development Alavattam Sreedhara, Jian Yin, Michael Joyce, European Journal of Pharmaceutics and Biopharmaceutics Immunocytochemical TechniqueAllergyIgg1 Monoclonal AntibodiesAmbient LightImmunology	2015	91
Substrate Specificity Changes for Human Reticulocyte and Epithelial 15-Lipoxygenases Reveal Allosteric Product Regulation Aaron T. Wecksler, Victor Kenyon, Joshua D. Deschamps, Biochemistry	2008	66
Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy Hiromi Inoue, Sung Hee Hwang, Aaron T. Wecksler, Cancer Biology & Therapy OncologySeveral RccDna-damaging ChemotherapyMedicineOncogenic Agent	2011	63
Mapping the Binding Interface of VEGF and a Monoclonal Antibody Fab-1 Fragment with Fast Photochemical Oxidation of Proteins (FPOP) and Mass Spectrometry Ying Zhang, Aaron T. Wecksler, Patricia G. Molina, Journal of the American Society for Mass Spectrometry Immunocytochemical TechniqueBiological Mass SpectrometryMolecular BiologySolvent AccessibilityProtein Folding	2017	63
A novel p21 attenuator which is structurally related to sorafenib Hiromi I. Wettersten, Sung Hee Hwang, Cuiwen Li, Cancer Biology & Therapy Chemoprevention StrategyMolecular BiologyCancer BiologyTumor BiologyMolecular Pharmacology	2013	60

Page 1